METASTATIC CUTANEOUS MELANOMA (STAGE IV)

Clinical trials for METASTATIC CUTANEOUS MELANOMA (STAGE IV) explained in plain language.

Never miss a new study

Get alerted when new METASTATIC CUTANEOUS MELANOMA (STAGE IV) trials appear

Sign up with your email to follow new studies for METASTATIC CUTANEOUS MELANOMA (STAGE IV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New Two-Pronged attack tested for Tough-to-Treat skin cancer

Disease control Ongoing

This study is testing whether a new drug called acasunlimab works better alone or combined with an existing cancer drug (pembrolizumab) for people with advanced skin melanoma that has continued to grow despite prior immunotherapy. All participants will receive active treatment—no…

Matched conditions: METASTATIC CUTANEOUS MELANOMA (STAGE IV)

Phase: PHASE2 • Sponsor: Genmab • Aim: Disease control

Last updated Apr 04, 2026 10:05 UTC

METASTATIC CUTANEOUS MELANOMA (STAGE IV)

Get alerted when new METASTATIC CUTANEOUS MELANOMA (STAGE IV) trials appear

New Two-Pronged attack tested for Tough-to-Treat skin cancer